Clinical Trials Directory

Trials / Completed

CompletedNCT07068282

The Effect of Novel D3 Use as a Mouthwash in COVID-19 Patients

Vitamin D3, Mouthwash, Saliva Testing, Covid-19, Antiviral Testing

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
25 (actual)
Sponsor
King Faisal Specialist Hospital & Research Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The PI's goal of this \[interventional/clinical trial\] is to \[explore the antiviral properties of vitamin D3 on saliva samples collected before and after the use of a vitamin D3 mouthwash\] in \[ adult participants, both genders, with COVID-19 who tested positive on a swab test\]. The main question\[s\] aims to answer \[is\]: \[Assess the antiviral potential of a novel vitamin D-based mouthwash in COVID-19-positive participants\]. PI will compare both \[Control group: saliva only- before use of mouthwash\], and the \[study group: after use of the mouthwash in saliva\] to see if there is \[any veridical effect present in saliva after running lab tests\]. Participants will \[self-collect saliva in a given tube (color coded orange), then 10-15 minutes later or more, participants will swish with D3 mouthwash, and will give another sample \[saliva + mouthwash\] in another (green labeled tube). For each participant, each of the following will be given: * 2 collecting tubes: orange labeled tube (for saliva collection only) and green labeled tube (for saliva collection after mouthwash use). * The vial containing vitamin D3 mouthwash.

Detailed description

Twenty-five adult participants confirmed COVID-19-positive, via rapid antigen testing (RAT) thru nasal swabs (NS), followed by saliva samples collected before and after using a vitamin D3 mouthwash. Samples were analyzed using RAT and rapid polymerase chain reaction (R-PCR) to measure viral load.

Conditions

Interventions

TypeNameDescription
DRUGCholecalciferol (vitaminD3)Vitamin D3 mouthwash was prepared for COVID-19 participants, to compare between the saliva only (control group), and with the use of mouthwash in saliva after the participants swish for 60 seconds (experimental group) and compare the effect of vitamin D over the virus in saliva, from both groups by testing via RAT and R-PCR.

Timeline

Start date
2024-07-24
Primary completion
2025-01-25
Completion
2025-02-12
First posted
2025-07-16
Last updated
2025-07-16

Locations

1 site across 1 country: Saudi Arabia

Source: ClinicalTrials.gov record NCT07068282. Inclusion in this directory is not an endorsement.